Lumos Pharma Inc. | Eigenkapital Und Reserven

Name: Lumos Pharma Inc. | Eigenkapital Und Reserven
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Equity Capital And Reserves		Datum
Agenus AGEN:US	$ 3.42M	12.3M	2022-06
Bristol Myers Squibb BMY:US	$ 32600M	1020M	2022-06
Capricor Therapeutics CAPR:US	$ 18.73M	5.91M	2022-06
Celldex Therapeutics CLDX:US	$ 365.09M	33.01M	2022-06
Eli Lilly And LLY:US	$ 8544.7M	786.1M	2022-06
Idera Pharmaceuticals IDRA:US	$ 21.13M	4.71M	2022-06
Intrexon XON:US	$ 55.65M	18.18M	2022-06
Nektar Therapeutics NKTR:US	$ 458.73M	149.16M	2022-06
Newlink Genetics NLNK:US	$ 74.55M	7.27M	2022-06
Prothena PRTA:US	$ 407.3M	31.59M	2022-06
Sarepta Therapeutics SRPT:US	$ 726.46M	130.43M	2022-06
Vascular Biogenics VBLT:US	34.37M	8.42M	2022-06
YTE INCY:US	$ 4085.06M	221.99M	2022-06

Lumos Pharma Inc. Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.